Skip to content

Mechanisms of Acupuncture Intervention for Amnestic Mild Cognitive Impairment Based on Multimodal Brain Functions

Mechanisms of Acupuncture Intervention for Amnestic Mild Cognitive Impairment Based on Multimodal Brain Functions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000418
Enrollment
Unknown
Registered
2025-02-27
Start date
2022-12-31
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amnestic mild cognitive impairment

Interventions

verum acupuncture group:acupuncture
control group:none

Sponsors

Shenzhen traditional Chinese medicine hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 75 Years

Inclusion criteria

Inclusion criteria: Meet the aMCI diagnostic criteria: (Perterson 2004 criteria) : (1) Memory loss is the main complaint and it is confirmed by informed persons; (2) Objectively existing memory decline that is inconsistent with age; (3) General cognitive function is basically normal; (4) The ability of daily living is basically normal; (5) The degree of cognitive impairment is not sufficient to diagnose dementia. 2) There are symptoms of memory impairment and the course of the disease is >3 months; 3) The score of the Simple mental State Examination Scale (MMSE) is greater than or equal to 24 points; The overall score of the Clinical Dementia Rating Scale (CDR) was 0.5 and the memory domain was at least 0.5; 5) Age 50-75 years old primary school education or above; The ability of daily living was not affected and the scale (ADL) score was =26; 7) Right-handed Han nationality; 8) Willing to cooperate and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) Patients who have received cognitive function related treatment within the past 1 month; Use of drugs that may affect cognitive function in the past 1 month including sedatives anti-anxiety drugs hypnotics and psychotropic drugs Drugs and cholinomimetic drugs; (3) Previous history of stroke brain tumor Parkinson's disease encephalitis epilepsy and brain trauma; (4) Obvious white matter lesions (Fazekas score = 3-6); 5) Patients with serious mental illness alcoholics drugs or other psychotropic drug abusers; 6) Severe hearing visual impairment and aphasia resulting in inability to achieve the assessment and failure to complete the test; A history of severe head trauma or other diseases involving the central nervous system affect the neuropsychological scale assessment Estimator; 8) have serious heart liver renal insufficiency and other systemic diseases; 9) Patients with contraindications of MRI or other subjects deemed unsuitable by the researchers

Design outcomes

Primary

MeasureTime frame
MoCA;

Secondary

MeasureTime frame
AVLT-H;HAMD-17;MRI;CDR;OCT;MMSE;ADL;

Countries

China

Contacts

Public ContactLiu Yongfeng

Shenzhen Traditional Chinese Medicine Hospital

2608640237@qq.com13480752834

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026